Andrew Orry

2.1k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Andrew Orry is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, Andrew Orry has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 6 papers in Computational Theory and Mathematics. Recurrent topics in Andrew Orry's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew Orry is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew Orry collaborates with scholars based in United States, Australia and United Kingdom. Andrew Orry's co-authors include Claudio N. Cavasotto, Ruben Abagyan, B.A. Wallace, Robert W. Janes, Erin M. Bowers, Philip A. Cole, Cecilia Larocca, S. Adrian Saldanha, David J. Meyers and Yan Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Andrew Orry

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor

2010 504 citations Erin M. Bowers, Gai Yan et al. Chemistry & Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Orry United States	17	1.3k	341	248	168	163	37	1.6k
Karl A. Walter United States	20	1.1k 0.9×	222 0.7×	280 1.1×	105 0.6×	162 1.0×	34	1.8k
Peter Chase United States	24	1.2k 0.9×	248 0.7×	214 0.9×	224 1.3×	221 1.4×	68	2.0k
Ana P. C. Rodrigues United States	6	1.6k 1.2×	223 0.7×	133 0.5×	87 0.5×	134 0.8×	6	2.3k
S. Adrian Saldanha United States	22	1.5k 1.2×	186 0.5×	220 0.9×	233 1.4×	246 1.5×	32	2.2k
Maulik Patel United States	25	981 0.8×	167 0.5×	181 0.7×	148 0.9×	218 1.3×	73	1.7k
Tara Mirzadegan United States	16	933 0.7×	200 0.6×	301 1.2×	154 0.9×	295 1.8×	25	1.5k
Karim M. ElSawy United Kingdom	11	1.2k 1.0×	236 0.7×	83 0.3×	101 0.6×	166 1.0×	26	1.7k
HaJeung Park United States	27	1.7k 1.3×	129 0.4×	270 1.1×	264 1.6×	294 1.8×	68	2.4k
Xin‐Qiu Yao United States	18	1.2k 0.9×	230 0.7×	119 0.5×	68 0.4×	158 1.0×	47	1.6k
Wendy Lea United States	18	1.1k 0.8×	135 0.4×	102 0.4×	229 1.4×	130 0.8×	32	1.7k

Countries citing papers authored by Andrew Orry

Since Specialization

Citations

This map shows the geographic impact of Andrew Orry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Orry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Orry more than expected).

Fields of papers citing papers by Andrew Orry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Orry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Orry. The network helps show where Andrew Orry may publish in the future.

Co-authorship network of co-authors of Andrew Orry

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Orry. A scholar is included among the top collaborators of Andrew Orry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Orry. Andrew Orry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Habas, Agata, Emily M. Stocking, Andrew Orry, et al.. (2025). Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists. Bioorganic & Medicinal Chemistry Letters. 124. 130259–130259. 1 indexed citations

Kao, Hung‐Teh, Andrew Orry, Michael G. Palfreyman, & Barbara Porton. (2022). Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19. Scientific Reports. 12(1). 10174–10174. 7 indexed citations

Habas, Agata, Emily M. Stocking, Andrew Orry, et al.. (2021). Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists. Bioorganic & Medicinal Chemistry Letters. 40. 127861–127861. 6 indexed citations

Klika, Karel D., et al.. (2020). Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma. Frontiers in Pharmacology. 11. 549804–549804. 5 indexed citations

Bechard, Matthew E., et al.. (2019). Purification, kinetic characterization, and site-directed mutagenesis of <em>Methanothermobacter thermautotrophicus</em> RFAP Synthase Produced in <em>Escherichia coli</em>. AIMS Microbiology. 5(3). 186–204. 4 indexed citations

Desai, Aditya J., Céline Valant, Denise Wootten, et al.. (2018). Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor. Molecular Pharmacology. 95(3). 245–259. 5 indexed citations

Naschberger, Andreas, Andrew Orry, Stefan Lechner, et al.. (2017). Structural Evidence for a Role of the Multi-functional Human Glycoprotein Afamin in Wnt Transport. Structure. 25(12). 1907–1915.e5. 24 indexed citations

Dong, Maoqing, Polo C.‐H. Lam, Andrew Orry, et al.. (2016). Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor. Journal of Biological Chemistry. 291(10). 5172–5184. 9 indexed citations

Dong, Maoqing, Polo C.‐H. Lam, Andrew Orry, et al.. (2014). Development of a Highly Selective Allosteric Antagonist Radioligand for the Type 1 Cholecystokinin Receptor and Elucidation of Its Molecular Basis of Binding. Molecular Pharmacology. 87(1). 130–140. 10 indexed citations

10.

Wang, Jessica, Haiqing Yi, Dosuk Yoon, et al.. (2014). Differential Loss of Prolyl Isomerase or Chaperone Activity of Ran-binding Protein 2 (Ranbp2) Unveils Distinct Physiological Roles of Its Cyclophilin Domain in Proteostasis. Journal of Biological Chemistry. 289(8). 4600–4625. 16 indexed citations

11.

Harikumar, Kaleeckal G., Erin E. Cawston, Polo C.‐H. Lam, et al.. (2013). Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor. Journal of Biological Chemistry. 288(29). 21082–21095. 16 indexed citations

12.

Ferreira, Paulo A. & Andrew Orry. (2012). FromDrosophilato Humans: Reflections on the Roles of the Prolyl Isomerases and Chaperones, Cyclophilins, in Cell Function and Disease. Journal of Neurogenetics. 26(2). 132–143. 13 indexed citations

13.

Cawston, Erin E., Polo C.‐H. Lam, Kaleeckal G. Harikumar, et al.. (2012). Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor. Journal of Biological Chemistry. 287(22). 18618–18635. 20 indexed citations

14.

Orry, Andrew & Ruben Abagyan. (2011). Preparation and Refinement of Model Protein–Ligand Complexes. Methods in molecular biology. 857. 351–373. 11 indexed citations

15.

Bowers, Erin M., Gai Yan, Chandrani Mukherjee, et al.. (2010). Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor. Chemistry & Biology. 17(5). 471–482. 504 indexed citations breakdown →

16.

Cavasotto, Claudio N. & Andrew Orry. (2007). Ligand Docking and Structure-based Virtual Screening in Drug Discovery. Current Topics in Medicinal Chemistry. 7(10). 1006–1014. 197 indexed citations

17.

Orry, Andrew, Ruben Abagyan, & Claudio N. Cavasotto. (2006). Structure-based development of target-specific compound libraries. Drug Discovery Today. 11(5-6). 261–266. 54 indexed citations

18.

Cavasotto, Claudio N., Andrew Orry, & Ruben Abagyan. (2003). Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors. Proteins Structure Function and Bioinformatics. 51(3). 423–433. 63 indexed citations

19.

Orry, Andrew, et al.. (2001). Synchrotron radiation circular dichroism spectroscopy: vacuum ultraviolet irradiation does not damage protein integrity. Journal of Synchrotron Radiation. 8(3). 1027–1029. 8 indexed citations

20.

Orry, Andrew & B.A. Wallace. (2000). Modeling and Docking the Endothelin G-Protein-Coupled Receptor. Biophysical Journal. 79(6). 3083–3094. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact